Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications.
Turgeman I, Bar-Sela G. Turgeman I, et al. Isr Med Assoc J. 2017 Feb;19(2):85-88. Isr Med Assoc J. 2017. PMID: 28457056 Free article. Review.
Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
Turgeman I, Bar-Sela G. Turgeman I, et al. Expert Opin Investig Drugs. 2019 Mar;28(3):285-296. doi: 10.1080/13543784.2019.1561859. Epub 2018 Dec 29. Expert Opin Investig Drugs. 2019. PMID: 30572744 Review.
Severe complicated neutropenia in two patients with metastatic non-small-cell lung cancer treated with nivolumab.
Turgeman I, Wollner M, Hassoun G, Bonstein L, Bar-Sela G. Turgeman I, et al. Anticancer Drugs. 2017 Aug;28(7):811-814. doi: 10.1097/CAD.0000000000000520. Anticancer Drugs. 2017. PMID: 28574922
Fortuitous administration of denosumab in breast carcinoma with osteoclastic giant cells.
Turgeman I, Flechter E, Vlodavsky E, Militianu D, Keidar Z, Haddad E, Bar-Sela G. Turgeman I, et al. Anticancer Drugs. 2018 Jun;29(5):466-470. doi: 10.1097/CAD.0000000000000612. Anticancer Drugs. 2018. PMID: 29481473
Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors.
Finkel I, Sternschuss M, Wollner M, Shamai S, Peled N, Turgeman I, Shochat T, Dudnik E; Israel Lung Cancer Group. Finkel I, et al. Among authors: turgeman i. J Immunother. 2020 Feb/Mar;43(2):67-74. doi: 10.1097/CJI.0000000000000293. J Immunother. 2020. PMID: 31498181
Young patients with cancer and a digital social network: the voice beyond the clinic.
Ben-Aharon I, Goshen-Lago T, Turgeman I, Fontana E, Smyth E, Lordick F. Ben-Aharon I, et al. Among authors: turgeman i. ESMO Open. 2020 May;5(3):e000651. doi: 10.1136/esmoopen-2019-000651. ESMO Open. 2020. PMID: 32385087 Free PMC article.
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.
Lalazar G, Mizrahi M, Turgeman I, Adar T, Ben Ya'acov A, Shabat Y, Nimer A, Hemed N, Zolotarovya L, Lichtenstein Y, Lisovoder N, Samira S, Shalit I, Ellis R, Ilan Y. Lalazar G, et al. Among authors: turgeman i. J Clin Immunol. 2015 May;35(4):399-407. doi: 10.1007/s10875-015-0160-6. Epub 2015 Apr 17. J Clin Immunol. 2015. PMID: 25876706 Clinical Trial.
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.
Bar-Sela G, Cohen I, Campisi-Pinto S, Lewitus GM, Oz-Ari L, Jehassi A, Peer A, Turgeman I, Vernicova O, Berman P, Wollner M, Moskovitz M, Meiri D. Bar-Sela G, et al. Among authors: turgeman i. Cancers (Basel). 2020 Aug 28;12(9):2447. doi: 10.3390/cancers12092447. Cancers (Basel). 2020. PMID: 32872248 Free PMC article.
The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study.
Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, Almog R, Turgeman I, Zaltzman N, Halberthal M, Shaked Y, Ben-Aharon I. Goshen-Lago T, et al. Among authors: turgeman i. Cancers (Basel). 2020 Aug 26;12(9):2421. doi: 10.3390/cancers12092421. Cancers (Basel). 2020. PMID: 32859016 Free PMC article.